Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 12; Last updated: 2023-12-06 18:55:32+0000
Profiles: ComparativeEvidence, SingleStudyEvidence
url: https://fevir.net/resources/Evidence/47749
identifier: FEvIR Object Identifier/47749
name: ComparativeEvidence_Mean_difference_in_HbA1c_between_Surgery_and_Medical_Lifestyle_groups_in_Halperin_2014
title: ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Halperin 2014
status: Active
date: 2022-05-29 11:03:46+0000
author: Brian S. Alper:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparativeEvidence |
| Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatesTo
type: Derived From
relatesTo
type: Cite As
target:
ComparativeEvidence: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups in Halperin 2014 [Evidence]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 47749. Revised 2022-05-29. Available at: https://fevir.net/resources/Evidence/47749. Computable resource at: https://fevir.net/resources/Evidence/47749.
description:
Mean HbA1c at 12 months in Halperin 2014 was 6.2 % in Surgery group (n = 19) and 8.8% in Medical/Lifestyle group (n = 19), mean difference -2.60% (95% CI -3.37% to -1.83%)
variableDefinition
description:
38 patients aged 21 to 65 with T2DM and BMI 30 to 42 and HbA1c >= 6.5
variableRole: Population
observed: Halperin 2014 Trial Enrollment Group
variableDefinition
description:
Roux-en-Y Gastric Bypass vs. medical treatment (Weight Achievement and Intensive Treatment-Why WAIT)
variableRole: Exposure
comparatorCategory: medical treatment
observed: GroupAssignment: Roux-en-Y gastric bypass vs. medical treatment
variableDefinition
description:
HbA1c at 12 months
variableRole: Outcome
observed: HbA1c at 12 months
intended: OutcomeVariable: HbA1c at 12 months
synthesisType: not applicable
studyDesign: randomized assignment
statistic
description:
mean difference -2.60% (95% CI -3.37% to -1.83%)
note:
Mean HbA1c at 12 months in Halperin 2014 was 6.2 % in Surgery group (n = 19) and 8.8% in Medical/Lifestyle group (n = 19)
statisticType: Mean Difference
quantity: -2.6 % (Details: UCUM code% = '%')
SampleSizes
NumberOfParticipants KnownDataCount 38 38 AttributeEstimates
Description Type Level Range 95% CI -3.37% to -1.83%
Confidence interval 0.95 -3.37--1.83 %
IG © 2024+ HL7 International / Clinical Decision Support. Package hl7.fhir.uv.ebm#1.0.0-ballot2 based on FHIR 6.0.0-ballot3. Generated 2025-08-21
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change